Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The US Federal Trade Commission (FTC) announced Friday it sued three prescription drug benefit managing companies, alleging ...
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback